IRIS
LENCI, ILARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.398
AS - Asia 3.310
EU - Europa 1.352
SA - Sud America 378
AF - Africa 51
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 4
Totale 13.499
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.297
SG - Singapore 1.966
CN - Cina 452
RU - Federazione Russa 311
BR - Brasile 307
IT - Italia 262
VN - Vietnam 233
HK - Hong Kong 229
IE - Irlanda 155
DE - Germania 136
GB - Regno Unito 103
BD - Bangladesh 94
FR - Francia 87
JP - Giappone 78
KR - Corea 76
IN - India 71
FI - Finlandia 66
CA - Canada 53
PL - Polonia 42
MX - Messico 31
SE - Svezia 30
AR - Argentina 29
UA - Ucraina 28
ES - Italia 24
AT - Austria 21
ID - Indonesia 20
NL - Olanda 20
ZA - Sudafrica 14
BE - Belgio 13
CZ - Repubblica Ceca 11
TR - Turchia 11
CH - Svizzera 10
LT - Lituania 10
IQ - Iraq 9
IR - Iran 9
EC - Ecuador 8
EG - Egitto 8
PK - Pakistan 8
VE - Venezuela 8
CO - Colombia 7
CL - Cile 6
MA - Marocco 6
PY - Paraguay 6
IL - Israele 5
KE - Kenya 5
AU - Australia 4
AZ - Azerbaigian 4
EU - Europa 4
HN - Honduras 4
JM - Giamaica 4
PH - Filippine 4
QA - Qatar 4
SA - Arabia Saudita 4
TM - Turkmenistan 4
TN - Tunisia 4
AL - Albania 3
DZ - Algeria 3
JO - Giordania 3
LK - Sri Lanka 3
MD - Moldavia 3
OM - Oman 3
PE - Perù 3
SN - Senegal 3
TW - Taiwan 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
BB - Barbados 2
BG - Bulgaria 2
CR - Costa Rica 2
DK - Danimarca 2
KH - Cambogia 2
KZ - Kazakistan 2
NG - Nigeria 2
NO - Norvegia 2
RO - Romania 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BH - Bahrain 1
BJ - Benin 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CV - Capo Verde 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GR - Grecia 1
GY - Guiana 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
LV - Lettonia 1
MT - Malta 1
MY - Malesia 1
NP - Nepal 1
PA - Panama 1
PS - Palestinian Territory 1
Totale 13.495
Salva come PNG Salva come JPEG
Città #
Wilmington 1.914
Houston 1.575
Singapore 729
Woodbridge 520
New York 379
Ashburn 376
Fairfield 369
San Jose 348
Chandler 321
Hong Kong 220
Beijing 182
Council Bluffs 139
Dublin 134
The Dalles 128
Los Angeles 122
Seattle 118
Cambridge 115
Medford 105
Santa Clara 97
Rome 93
Ann Arbor 91
Ho Chi Minh City 87
Elk Grove Village 86
Tokyo 75
Hanoi 50
Lauterbourg 49
Helsinki 48
Lawrence 48
Buffalo 47
Munich 47
Moscow 39
São Paulo 33
Nuremberg 31
Orem 30
San Diego 30
Warsaw 30
London 29
Chicago 27
Dallas 27
Menlo Park 26
Montreal 23
North Bergen 23
Seoul 23
Chennai 21
Dearborn 21
Frankfurt am Main 18
Palo Alto 18
Mexico City 17
Redondo Beach 17
Brooklyn 15
Denver 15
Jacksonville 15
Atlanta 14
Creede 14
Engelhard 14
Jakarta 14
Phoenix 14
Stockholm 13
Boardman 12
Brussels 12
Lappeenranta 12
Miami 12
Milan 12
Shanghai 12
Vienna 12
Washington 11
Poplar 10
Redwood City 10
Rio de Janeiro 10
San Francisco 10
Biên Hòa 9
Colorado Springs 9
Johannesburg 9
Manchester 9
Nanjing 9
Toronto 9
Hangzhou 8
Hefei 8
Brno 7
Chandigarh 7
Da Nang 7
Hải Dương 7
Salt Lake City 7
Suzhou 7
Charlotte 6
Columbus 6
Haiphong 6
Hounslow 6
Madrid 6
Mumbai 6
Tampa 6
Amsterdam 5
Curitiba 5
Nairobi 5
New Delhi 5
Norwalk 5
Philadelphia 5
Porto Alegre 5
Ribeirão Preto 5
Shenzhen 5
Totale 9.557
Salva come PNG Salva come JPEG
Nome #
HCV-RNA quantification in liver bioptic samples and extrahepatic compartments, using the abbott RealTime HCV assay 527
Pitfalls in the reporting of upper endoscopy features in cirrhotic patients 446
Evidence of Spontaneous Post-transplant HCV Eradication in Two Failed DAA Treatments Awaiting Liver Transplantation 434
Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens 415
Ab initio Everolimus-based Versus Standard Calcineurin Inhibitor Immunosuppression Regimen in Liver Transplant Recipients 372
An unusual duodenal polyp causing anemia in a liver-transplanted patient 347
Sofosbuvir plus daclatasvir with or without ribavirin is safe and effective for post-transplant hepatitis C recurrence and severe fibrosis and cirrhosis: A prospective study 344
Tips for TIPS: A combined percutaneous and transjugular approach for intrahepatic portosystemic shunt placement after liver transplant 341
Clinical Operational Tolerance and Immunosuppression Minimization in Kidney Transplantation: Where Do We Stand? 339
HDV can constrain HBV genetic evolution in hbsag: Implications for the identification of innovative pharmacological targets 333
Hepatitis B virus recurrence after liver transplantation: An old tale or a clear and present danger? 330
Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows 310
Trans-splenic Embolization Plus Partial Splenic Embolization for Management of Variceal Bleeding Due to Left-Sided Portal Hypertension 303
Effect of direct-acting antivirals on future occurrence of hepatocellular carcinoma in compensated cirrhotic patients 302
Impact of new DAA therapy on real clinical practice: A multicenter region-wide cohort study 301
Pro-inflammatory signalling and gut-liver axis in non-alcoholic and alcoholic steatohepatitis: differences and similarities along the path 298
Recurrence of hepatocellular carcinoma after direct acting antiviral treatment for hepatitis C virus infection: Literature review and risk analysis 290
Renal Function, Adherence and Quality of Life Improvement After Conversion From Immediate to Prolonged-Release Tacrolimus in Liver Transplantation: Prospective Ten-Year Follow-Up Study 277
HCV resistance compartmentalization within tumoral and non-tumoral liver in transplanted patients with hepatocellular carcinoma 259
Dual role of bile acids on the biliary epithelium: Friend or foe? 249
Liver Transplantation For HDV/HBV Coinfection In Italy: An Intention-To-Treat Analysis Of Long-Term Outcomes 246
Platelets and hepatocellular cancer: Bridging the bench to the clinics 224
Evaluation of liver fibrosis in cirrhotic patients: comparison between elastosonography and fibroscan 214
Domino liver transplantation: Where are we now? 211
Liver transplantation for hepatocellular carcinoma: Where do we stand? 210
De novo malignancies after liver transplantation: The effect of immunosuppression-personal data and review of literature 205
Prevention of hepatitis C recurrence by bridging sofosbuvir/ribavirin from pre- to post-liver transplant: A real-life strategy 205
Vascular anomalies of the celiac trunk and implications in treatment of HCC with TACE. Description of a case and review of the literature 202
Daclatasvir, sofosbuvir with or without ribavirin for 24 weeks in hepatitis C genotype 3 cirrhosis: A real-life study 159
Cholangiocarcinoma: Bridging the translational gap from preclinical to clinical development and implications for future therapy 150
Genetic Determinants in a Critical Domain of NS5A Correlate with Hepatocellular Carcinoma in Cirrhotic Patients Infected with HCV Genotype 1b 136
Transarterial chemoembolization for hepatocellular carcinoma in Fontan surgery patient 135
Moving forward in the treatment of cholangiocarcinoma 130
Fairness and pitfalls of the Italian waiting list for elective liver transplantation: The ECALITA registry study 127
Serum Levels of Granulocyte-Macrophage-colony-stimulating Factor and Stem-cell Factor During Liver Regeneration after Partial Hepatectomy in Humans 119
Current strategies to minimize ischemia-reperfusion injury in liver transplantation: a systematic review 113
Natremia and liver transplantation: The right amount of salt for a good recipe 108
Molecular mechanisms linking risk factors to cholangiocarcinoma development 107
Overview of prognostic systems for hepatocellular carcinoma and ITA.LI.CA external validation of MESH and CNLC classifications 106
Chronic rejection after liver transplantation: Opening the Pandora's box 104
Cyclic AMP Signaling in Biliary Proliferation: A Possible Target for Cholangiocarcinoma Treatment? 101
Prevalence of hepatitis D virus infection in Central Italy has remained stable across the last 2 decades with dominance of subgenotypes 1 and characterized by elevated viral replication 99
Functional Role of the Secretin/Secretin Receptor Signaling During Cholestatic Liver Injury 99
Gastrointestinal endoscopy in cirrhotic patient: Issues on the table 98
COVID-19 in normal, diseased and transplanted liver 98
Electronic Outpatient Referral System for Liver Transplant Improves Appropriateness and Allows First Visit Triage 98
Liver transplantation performed in a SARS-CoV-2 positive hospitalized recipient using a SARS-CoV-2 infected donor 95
Resistance analysis and treatment outcomes in hepatitis C virus genotype 3-infected patients within the Italian network VIRONET-C 95
The role of antiplatelet therapies on incidence and mortality of hepatocellular carcinoma 94
The acquisition of positively charged amino acids in HBsAg C-terminus correlates with HBV-induced liver cancer in vivo, impairs HBsAg secretion and affects its structural stability in vitro 93
Correction to: Immunosuppressive regimens for adult liver transplant recipients in real-life practice: consensus recommendations from an Italian Working Group (Hepatology International, (2020), 14, 6, (930-943), 10.1007/s12072-020-10091-5) 90
Waiting list mortality and 5-year transplant survival benefit of patients with MASLD: An Italian liver transplant registry study 90
Successful clinical and virological outcomes of liver transplantation for HDV/HBV-related disease after long-term discontinuation of hepatitis B immunoglobulins 88
HDV replicative activity parallels the production of the three HBsAg forms (Large, Middle and Small HBsAg) and its pathogenetic impact is exacerbated by concomitant HBV replication 87
HDV epidemic in Central Italy is stable over the last two decades and is characterized by the circulation of multiple HDV subgenotypes 1 inducing different inflammatory stimuli 87
Superiority of the new sex-adjusted models to remove the female disadvantage restoring equity in liver transplant allocation 86
Secondary bile acids and the biliary epithelia: The good and the bad 84
Towards tolerance in liver transplantation 84
The acquisition of positively charged amino acids in HBsAg C- terminus impairs HBsAg secretion, affects its structural stability and is associated with HBV-induced liver cancer 81
Stable temporal trend of HDV seroprevalence in central Italy across the last two decades with the circulation of HDV sub-genotypes 1 inducing different inflammatory stimuli 79
Role of Cone-Beam CT in the Intraprocedural Evaluation of Chemoembolization of Hepatocellular Carcinoma 78
New strategies on management of hepatitis B virus after liver transplantation: complete and sustained weaning of HBV prophylaxis in a selected cohort of patients transplanted due to HBV-related cirrhosis 78
Successful ongoing retreatment with glecaprevir/pibrentasvir + sofosbuvir + ribavirin in a patient with HCV genotype 3 who failed glecaprevir/pibrentasvir with both NS3 and NS5A resistance 77
A peculiar HBsAg isoforms composition characterizes chronic HDV coinfection respect to HBV mono-infection, with higher middle-/large-HBs levels paralleling HDV activity. 76
Higher levels of three HBsAg forms (Large, Middle and Small HBsAg) are associated with HDV replication and with the degree of disease and liver damage. 76
The Italian data on SARS-CoV-2 infection in transplanted patients support an organ specific immune response in liver recipients 75
Sequence of events leading to primary biliary cholangitis 72
Sarco-Model: A score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation 71
Chronic HDV coinfection (CHD) is characterized by a more elevated production of Middle and Large HBsAg than HBV mono-infection, that parallels HDV replicative and cytolytic activity. 71
HDV INFECTION IS STABLE IN CENTRAL ITALY ACROSS THE LAST TWO DECADES AND IS CHARACTERIZED BY THE CIRCULATION OF MULTIPLE HDV SUB-GENOTYPES 1 WITH A DIFFERENT PRO-INFLAMMATORY POTENTIAL 71
Chronic HDV coinfection (CHD) is characterized by a different HBsAg isoforms composition respect to HBV mono-infection with higher middle- and large-HBs levels paralleling the replicative and cytolytic activity of HDV. 70
Benign disease and unexpected histologocal findings after pancreaticoduodenectomy: The role of endoscopic ultrasound fine needle aspiration 70
Repeated TACE in HCC after Fontan surgery and situs viscerum inversus: A case report 68
THE ENRICHMENT OF POSITIVELY CHARGED AMINO ACIDS IN HBsAg C-TERMINUS IMPAIRS HBsAg SECRETION, AFFECTS ITS STRUCTURAL STABILITY AND IS CORRELATED WITH HBV-INDUCED LIVER CANCER. 68
The Many Faces of Metabolic Dysfunction-Associated Fatty Liver Disease Treatment: From the Mediterranean Diet to Fecal Microbiota Transplantation 68
The intrahepatic activity of Hepatitis Delta virus is sustained by an abundant production of HBs transcripts, mainly derived from integrated HBV-DNA, and is not strictly related to the extent of HBV reservoir 68
Development of Autoimmune Hepatitis after COVID-19 Infection in Vaccinated Women 66
PATHWAYS UNDERLYING HDV PERSISTENCE ACT INDEPENDENTLY FROM THE EXTENT OF HBV RESEVOIR AND ARE SUSTAINED BY AN ABUNDANT PRODUCTION OF HBSAG DERIVED FROM INTEGRATED HBV-DNA P 214 66
The Effects of Sustained Immunosuppression Withdrawal After Liver Transplantation on Metabolic Syndrome 63
Reduction in bile leaks following adult split liver transplant using a fibrin-collagen sponge: A pilot study 61
Chronic HDV infection is sustained by an intense HBsAg production fromintegrated HBVDNA in the setting of a limited or even absent HBV reservoir. 60
Chronic HDV coinfection is characterized by a peculiar HBsAg isoforms composition respect to HBV mono-infection, with higher middle-/large-HBs levels paralleling HDV activity. 57
Sarco-Model: a score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation 56
Use of intravascular ultrasound to improve diagnosis and treatment of transjugular intrahepatic portosystemic shunt dysfunction in patients in the long-term follow-up 54
HDV persistence is sustained by HBsAg mainly derived from integrated HBV-DNA and is independent from the extent of HBV reservoir 54
Pathways sustaining HDV activity act independently from the size of HBV resevoir and are fueled by an abundant expression of HBsAg from integrated HBV-DNA 53
HBsAg production from integrated HBV-DNA sustains HDV persistence in the setting of a limited or even absent HBV reservoir 52
Saline Contrast Echocardiography in Patients With Hepatopulmonary Syndrome Awaiting Liver Transplantation 45
null 42
HDV persistence acts independently from HBV reservoir extent and is sustained by HBsAg production mainly derived from integrated HBV-DNA 29
A high degree of genetic variability characterises HDV sub-genotypes 1 and can drive the selection of divergent genetic pathways modulating HDV replicative potential and cytolytic activity. 25
HBV integration can sustain intrahepatic HDV activity and can modulate HBV pathogenetic potential. 22
null 22
HDV sub-genotype 1 is characterized by increased genetic variability, which can promote the emergence of divergent genetic pathways that modulate HDV replicative potential and cytolytic activity. 20
HDV sub-genotype 1 is characterized by increased genetic variability, which can promote the emergence of divergent genetic pathways that modulate HDV replicative potential and cytolytic activity. 17
An increased genetic variability characterises HDV sub-genotypes 1 and can drive the selection of divergent genetic pathways modulating HDV replicative potential and cytolytic activity 16
Intra-hepatic HDV replicative activity can be sustained by HBsAg production from HBV-DNA integration and can modulate virological response to bulevirtide 15
Chronic HDV Infection Shows Higher HBsAg Isoform Levels than HBV Infection, Paralleling HDV Replicative Activity 9
Totale 13.915
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.655
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.655
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022606 28 62 18 27 9 72 46 24 71 60 38 151
2022/2023805 75 79 46 88 80 156 72 72 73 11 32 21
2023/2024478 60 16 43 13 62 135 9 14 14 54 3 55
2024/20252.580 56 347 205 105 28 183 165 60 170 181 620 460
2025/20264.356 423 146 414 421 362 337 511 481 539 368 211 143
2026/202738 38 0 0 0 0 0 0 0 0 0 0 0
Totale 13.915